About the Company
Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California.
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $EYES News
Vivani Medical, Inc. (VANI)
ALAMEDA, Calif., March 26, 2024--Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, long-term drug implants including its lead ...
Vivani Medical: Q4 Earnings Snapshot
EMERYVILLE, Calif. — EMERYVILLE, Calif. — Vivani Medical, Inc. (VANI) on Tuesday reported a loss of $6 million in its fourth quarter. The Emeryville, California-based company said it had a ...
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants including its ...
Vivani Medical Inc (VANI)
Despite the market sell-off on Friday, Second Sight Medical Products (O:EYES) shares showed some strength for the second consecutive day and recovered some of their losses in the ...
Vivani Medical Inc VANI
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Vivani Medical Inc (VANI)
ALAMEDA, Calif. - Vivani Medical, Inc. (NASDAQ: VANI), a biopharmaceutical company focused on long-term drug implants, announced the appointment of Daniel Bradbury to its Board of ...
Loading the latest forecasts...